CARDIO DIAGNOSTICS, LLC

Chicago, IL · Founded 2020 · Medtech · Public

Cardiovascular care delivery services including prevention, diagnostics, and treatment

Claim this profile

Follows are private to you and power your alerts

Updated · cardio.com

Sector
Medtech
Headquarters
Chicago, IL
Founded
2020
Latest Form D
$10M offered, May 2022
Total capital
$1.3M
Federal grants
$225K
1 award · 2019
Rank in peer group#44 of 50
Private capital raised
$1.1M
2 Form D · last May 2022
53 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2019202020212022FEDERAL ↑EQUITY ↓Cumulative $11.3M$225K1st Form D$1.1M2nd Form D$10M
2019202020212022FEDERAL ↑EQUITY ↓Cumulative $11.3M$225K1st Form D$1.1M

Latest events

  • Offering registeredForm D · SEC · 2nd filing$10M
  • Private capital raisedForm D · SEC · 1st filing$1.1M
  • Federal grantHealth and Human S · Phase I · An Integrated Genetic-Epigenetic Tool for the Prediction of CHD Incidence in African-Americans$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

27months

from CARDIO DIAGNOSTICS, LLC’s first federal award to its first private round.

First federal award · Sep 2019
Health and Human S · $225K
First Form D · Dec 2021
$1.1M · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 50 peers

Line = median

Medtech · Software

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Elisa LuqmanExecutive OfficerNamed in SEC Form D filings
  • Meeshanthini DoganExecutive Officer, DirectorNamed in SEC Form D filings
  • Robert PhilibertExecutive Officer, DirectorNamed in SEC Form D filings
  • Warren HosseinionDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • FirstVitals Inc.Similar federal contract value in Medtech · null in contracts
  • DIADEM US, INC.Similar federal contract value in Medtech · null in contracts
  • RECOVERY FORCE, LLCSimilar federal contract value in Medtech · null in contracts
  • FITOTO TECHNOLOGIES INC.Similar federal contract value in Medtech · null in contracts
  • Alio, Inc.Similar federal contract value in Medtech · null in contracts
  • Trugenomix Health, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .